骨成長刺激装置市場- 世界の産業規模、シェア、動向、成長機会、予測、タイプ別、用途別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

骨成長刺激装置の世界市場規模は2024年に12億4,000万米ドルで、予測期間中のCAGRは5.19%で2030年には16億8,000万米ドルに達すると予測されています。

骨成長刺激装置の世界市場は、高齢者人口の増加や、世界中で骨疾患とともに偶発的な傷害が増加していることを背景に、大きな成長を遂げています。さらに、関節炎、糖尿病様疾患、肥満、血管疾患、腎障害のような他の病状の有病率の上昇、低侵襲性および非侵襲性の外科治療に対する需要の増加が、長年にわたって市場の成長を促進する主な要因となっています。さらに、骨折や整形外科疾患の治療のために骨成長刺激因子によって提供される骨成長刺激因子と手続き上の利点に関する意識の高まりは、予測期間中の市場成長をさらに後押ししています。

市場促進要因

骨疾患と骨折の発生率の増加

主な市場課題

骨成長刺激装置デバイスの高コスト

主要市場動向

ウェアラブル技術とスマート技術の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の骨成長刺激装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（外部骨成長刺激装置、超音波骨成長刺激装置、インプラント骨成長刺激装置）
  • 用途別（脊椎固定術、骨癒合遅延および骨癒合不全骨折、口腔外科および顎顔面外科、その他）
  • エンドユーザー別（病院および外来手術センター、在宅ケア施設、学術研究機関）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第6章 北米の骨成長刺激装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の骨成長刺激装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の骨成長刺激装置市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の骨成長刺激装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの骨成長刺激装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の進歩
• 製品上市
• 合併と買収

第13章 世界の骨成長刺激剤市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Colfax Corporation
• Arthrex
• Essex Woodlands Healthcare Partners
• Isto Biologics
• Johnson and Johnson
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Bone Growth Stimulator Market was valued at USD 1.24 billion in 2024 and is expected to reach USD 1.68 billion by 2030 with a CAGR of 5.19% during the forecast period. The global market for Bone Growth Stimulator is experiencing significant growth, driven by the growing geriatric population along with the increasing incidences of accidental injuries along with bone disorders across the globe. Additionally, the rising prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, vascular diseases, renal disorder and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about bone growth stimulators and procedural benefits provided by bone growth stimulators for the treatment of bone fracture and orthopedic diseases is further boosting the market growth during the forecast period.

Key Market Drivers

Rising Incidence of Bone Disorders and Fractures

A key driver of the bone growth stimulator market is the global rise in the incidence of bone-related conditions, including fractures, osteoporosis, and spinal disorders. According to the World Health Organization (WHO), osteoporosis is estimated to affect more than 200 million people globally, with millions suffering fractures because of weakened bones. In the U.S. alone, the Centers for Disease Control and Prevention (CDC) reports over 8.9 million osteoporotic fractures annually. The aging population is a major contributor to this increase, with the United Nations projecting that the global population aged 65 and above will more than double from 761 million in 2021 to 1.6 billion by 2050. As bone healing tends to be slower in elderly individuals, the demand for non-invasive, supportive treatments like bone growth stimulators is growing. These devices, which use ultrasound or electrical pulses to stimulate natural bone regeneration, are increasingly adopted post-surgery and in complex fractures. Additionally, sports-related injuries in younger demographics have also contributed to the growing demand, with bone stimulators offering an effective adjunct therapy to speed up healing.

Key Market Challenges

High Cost of Bone Growth Stimulator Devices

Despite their clinical benefits, bone growth stimulators remain relatively expensive and are often not accessible to a wide segment of the population, particularly in low- and middle-income countries. The upfront cost of a single device can run into thousands of dollars, posing a financial barrier for patients without insurance or adequate healthcare coverage. Even in developed nations, many private insurers and national health services impose stringent guidelines for reimbursement, limiting patient access unless certain clinical criteria are met. According to Medicare guidelines in the U.S., coverage is generally limited to specific non-union fractures that haven't shown signs of healing after 90 days, excluding broader use cases such as preventive post-operative care. Additionally, the recurring costs associated with consumables, servicing, and clinician training further burden hospitals and healthcare providers. These cost-related barriers hinder widespread adoption, particularly in emerging markets where healthcare budgets are limited. Without broader reimbursement frameworks or subsidy programs, the penetration of these devices remains constrained despite clinical efficacy.

Key Market Trends

Integration of Wearable and Smart Technologies

A growing trend in the bone growth stimulator market is the incorporation of wearable and smart technology features into traditional stimulation devices. With increasing digitization in healthcare, next-generation stimulators are being developed with features such as Bluetooth connectivity, real-time treatment tracking, mobile app integration, and data analytics. These innovations help clinicians monitor patient compliance, treatment effectiveness, and adjust protocols remotely. In line with global efforts to promote home-based healthcare and reduce hospital remissions, such advancements improve both the convenience and outcomes of bone healing treatments. Governments and health authorities, including the European Commission's eHealth Action Plan, are increasingly supporting digital health innovations that reduce the burden on centralized health systems. By integrating sensors and AI-driven insights, companies are creating personalized therapy plans that align with the broader movement toward precision medicine. As wearable technologies become more affordable and user-friendly, their role in orthopedic rehabilitation is expected to expand significantly.

Key Market Players

• Colfax Corporation
• Arthrex
• Essex Woodlands Healthcare Partners
• Isto Biologics
• Johnson and Johnson
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings

Report Scope:

In this report, the Global Bone Growth Stimulator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Growth Stimulator Market, By Type:

• External Bone Growth Stimulators
• Ultrasonic Bone Growth Stimulators
• Implanted Bone Growth Stimulators

Bone Growth Stimulator Market, By Application:

• Spinal Fusion Surgeries
• Delayed Union and Non-union Bone Fractures
• Oral and Maxillofacial Surgeries
• Others

Bone Growth Stimulator Market, By End User:

• Hospital and Ambulatory Surgery Centres
• Home Care Settings
• Academic and Research Institutes

Bone Growth Stimulator Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Bone Growth Stimulator Market.

Available Customizations:

Global Bone Growth Stimulator Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone Growth Stimulator Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 5.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 5.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Bone Growth Stimulator Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 6.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 6.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bone Growth Stimulator Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bone Growth Stimulator Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bone Growth Stimulator Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Bone Growth Stimulator Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 7.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 7.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Bone Growth Stimulator Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Bone Growth Stimulator Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bone Growth Stimulator Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bone Growth Stimulator Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bone Growth Stimulator Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Bone Growth Stimulator Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 8.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 8.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bone Growth Stimulator Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bone Growth Stimulator Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bone Growth Stimulator Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Bone Growth Stimulator Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bone Growth Stimulator Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Bone Growth Stimulator Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 9.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 9.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bone Growth Stimulator Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Bone Growth Stimulator Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Bone Growth Stimulator Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Bone Growth Stimulator Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 10.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 10.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bone Growth Stimulator Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Bone Growth Stimulator Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Bone Growth Stimulator Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Advancements
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Bone Growth Stimulators Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Colfax Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Arthrex
• 15.3. Essex Woodlands Healthcare Partners
• 15.4. Isto Biologics
• 15.5. Johnson and Johnson
• 15.6. Medtronic Plc
• 15.7. Orthofix Medical Inc.
• 15.8. Stryker Corporation
• 15.9. Terumo Corporation
• 15.10. Zimmer Biomet Holdings

16. Strategic Recommendations

17. About Us & Disclaimer